Complex pregnancy is a game of pass the parcel. In every case report we receive, the authors remind us of the need for multidisciplinary care. Frequently, when the music stops, it is the neonatologist who is left 'holding the baby'. It was not long ago that neonatal clinicians faced a neonatal death almost weekly in level 3 units. A close colleague was recently relating that in one week he attended five babies that died. I remember as a registrar I would prepare the monthly perinatal morbidity/ mortality meeting and there would be several deaths and dozens of major morbidities.
We owe a great deal to the New Zealand scientist Sir Graham 'Mont' Liggins and his co-workers. The advent of antenatal steroids greatly improved the outcome for premature babies. This also reduced the time a newborn spent on the ventilator. The next critical advance in neonatal intensive care came with the availability of surfactant. In the early 1980s a registrar would insert an intercostal drain for a pneumothorax at least every couple of weeks. In some instances the risk of a pneumothorax was up to 25% for babies on a ventilator. Robertson and co-workers first showed the potential for animal-derived surfactants to treat respiratory distress syndrome in a rabbit model in 1973 and Fujiwara reported the treatment of newborn infants with surfactant in 1980. Since its widespread introduction into clinical use in the early 1990s, the mortality from respiratory distress syndrome has reduced from 30 to 5%. One impact of these critical advances was the temptation to lower the threshold for 'early' delivery in women with medical problems. This meant that neonatal units were full of 32-36 weekers with mild hyaline membrane disease and low blood glucose.
Along with progress in fetal monitoring, the advent of obstetric physicians has made a significant impact on the ability of obstetricians to confidently prolong pregnancy. It is not uncommon for obstetric physicians to 'undo' the advice of other physicians or surgeons regarding the necessity for Caesarean delivery in women with medical problems. My first encounter with pre-eclampsia as a junior registrar was an urgent Caesarean section for a mother with 'uncontrollable' blood pressure. The baby was growth restricted and preterm. The mother was on the verge of fitting. I asked what medications the mother was on; the reply was an assertive 'half an Aldomet bd'. An individual generalist obstetrician sees few cases of severe pre-eclampsia per year, while a busy obstetric physician will help manage many such women. The management of the above case in 2013 would be quite different. Similarly, poorly controlled diabetes was common, resulting in frequent prolonged admissions of term babies to the neonatal unit for days of blood glucose stabilization. For most women with diabetes now, including pre-pregnancy diabetes, separation from their baby following delivery is very unlikely.
From improved diagnosis to better maternal management, much of the work of obstetric physicians will have an impact on neonatal morbidity and mortality. This new breed of physicians understands the fetal and neonatal implications of managing maternal disease. There are many reasons that a baby may end up in the Neonatal Intensive Care Unit. Women with medical disorders comprise an important subset of highrisk obstetrics with a disproportionate rate of preterm and/or urgent delivery. In these cases, from the neonatologists' point of view, we want a baby at maximal gestation but also in the best condition possible.
The involvement of obstetric physicians leads to more integrated, women-centred care with awareness of the needs of mother, fetus and neonate. Better maternal health should provide a safer physiological environment for the fetus to stay inside longer; making the neonatologists' job a little easier. 
